UPDATE: US: Pfizer tries to cool baby food "speculation"

By Dean Best | 24 February 2012

Pfizer has insisted claims it has allowed Mead Johnson and Danone to table a joint bid for its infant nutrition business is "speculation" and said no decision has been made over the future of the division.

The US pharmaceutical giant told just-food that a Reuters report that claimed Mead Johnson and Danone were set to battle with Nestle for the infant nutrition unit was "based on a source's speculation".

A spokesperson for Pfizer said the company was still "exploring the strategic alternatives" for its infant nutrition business.

"We're continuing to pursue the activities associated with evaluating all options, including sale, spin-off or other transaction. However, no decisions have been made at this point," the spokesperson said. "We continue to be in a  position to announce any decision in 2012, and continue to expect to complete any transactions that may result from this decision between July 2012 and July 2013."

Pfizer's infant nutrition business generated revenues of around $1.9bn in 2010. It sells products including infant formulas and growing-up milks in over 60 countries. It operates from five plants in Ireland, China, Singapore, the Philippines and Mexico.

Sectors: Baby food, Mergers & acquisitions

Companies: Pfizer, Mead Johnson, Danone, Nestle

View next/previous articles

Currently reading -

UPDATE: US: Pfizer tries to cool baby food "speculation"

There are currently no comments on this article

Be the first to comment on this article

Related articles

just the answer - Ella's Kitchen CEO and founder Paul Lindley

UK baby food group Ella's Kitchen has rapidly expanded to become a household name and pantry staple for parents with pre-school children. In this month's just the answer, Ella's Kitchen founder and CEO Paul Lindley talks to Katy Askew about the development of the brand and what the future might have in store.

Best bits: Commodity price pressure intensifies

For those watching commodity prices, the news took a turn for the worse on Friday. The US government again cut its forecast on corn yields as the impact of the worst drought in the country for 50 years continues to reveal itself.

Focus: Nestle Health Science sneaks under the radar

Nestle's health science division has continued to motor below the radar in the first half of 2012 and the group is confident of a bright future for the unit.

Welcome to the home of food information, insight & intelligence

Not a member? Join here

Decrease font sizeDecrease font sizeDecrease font size Increase font sizeIncrease font sizeIncrease font size Comment on this article Email this to a friend Print this page